Filter
716
Text search:
drug
dosing
Featured
Recommendations
102
New Publications
195
Language
Document type
No document type
418
Guidelines
153
Studies & Reports
76
Manuals
24
Training Material
15
Fact sheets
13
Strategic & Response Plan
10
Situation Updates
3
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
45
South Africa
33
Kenya
23
Tanzania
21
Ethiopia
17
Global
15
Zambia
14
Uganda
10
Nepal
10
Africa
10
Rwanda
9
Ghana
8
Namibia
8
Sierra Leone
7
Nigeria
7
Malawi
7
Western and Central Europe
7
Zimbabwe
6
Bangladesh
6
Myanmar / Burma
6
Philippines
5
Liberia
4
USA
4
Cambodia
4
South Sudan
3
Eswatini/ Swaziland
3
Lesotho
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
2
Syria
2
Argentina
2
Ukraine
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Burkina Faso
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Germany
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Brazil
1
Botswana
1
Angola
1
East and Southern Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
242
Clinical Guidelines
146
Women & Child Health
40
Public Health
24
Capacity Building
20
Key Resources
3
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
108
TB
85
AMR
62
Pharmacy
34
Mental Health
32
COVID-19
24
NCDs
20
NTDs
17
Caregiver
11
Ebola
8
Conflict
6
Rapid Response
5
Refugee
5
Cholera
4
Planetary Health
3
Polio
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Ethiopian Medicines Formulary
recommended
2nd edition
Accessed November, 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...